Oxolamine Citrate Salt (CAS 1949-20-8): Your Key Pharmaceutical Intermediate
Discover the efficacy of Oxolamine Citrate Salt for pharmaceutical applications, including its role as a cough suppressant.
Get a Quote & SampleProduct Core Value
Oxolamine Citrate Salt
Oxolamine Citrate Salt, identified by CAS No. 1949-20-8, is a crucial pharmaceutical intermediate. It is recognized for its anti-inflammatory properties and is extensively utilized as a cough suppressant, making it a valuable component in various medicinal formulations.
- Explore the benefits of Oxolamine Citrate Salt suppliers for your pharmaceutical needs.
- Learn why reputable Oxolamine Citrate Salt manufacturers are vital for consistent quality in drug production.
- Understand the application of Oxolamine Citrate Salt as an anti-inflammatory drug in various formulations.
- Discover the convenience of buying Oxolamine Citrate Salt with the right specifications for your research and development.
Advantages of Using Oxolamine Citrate Salt
High Purity and Quality
With an assay ranging from 98.0-102.0%, this pharmaceutical intermediate ensures reliable performance in your production processes, meeting stringent quality demands.
Versatile Pharmaceutical Applications
Its dual role as an anti-inflammatory drug and a cough suppressant makes it a versatile ingredient for developing advanced therapeutics.
Reliable Sourcing
Partner with trusted Oxolamine Citrate Salt suppliers to guarantee a steady and dependable supply chain for your manufacturing operations.
Key Applications
Pharmaceutical Synthesis
As a vital pharmaceutical intermediate, it is integral to the synthesis of various active pharmaceutical ingredients (APIs), contributing to the development of effective medications.
Cough Suppressants
Its efficacy as a cough suppressant makes it a sought-after ingredient for formulations targeting respiratory conditions and symptomatic relief.
Anti-inflammatory Formulations
The anti-inflammatory properties of Oxolamine Citrate Salt are leveraged in the creation of drugs aimed at reducing inflammation and related symptoms.
Drug Development
Researchers and manufacturers rely on Oxolamine Citrate Salt CAS 1949-20-8 for its consistent quality in drug development and commercial production.